Blumberg Institute Principal Investigators

Timothy Block, PhD  – Antivirals, Early Detection and Glycobiology
Mathew Casimiro, Ph.D. – Associate Professor
Jinhong Chang, MD, PhD – Antiviral drug discovery, hepatitis viruses, dengue, and filoviruses
Jason Clement, PhD– Natural products chemistry research
Chari Cohen, DrPH –Public Health research
Agnese Di Rocco, Ph.D. – Assistant Professor
Yanming Du, PhD – Medical chemistry, synthesis, drug design
Michael Goetz, PhD – Natural Products chemistry research
Ju-Tao Guo, MD – Innate host defense systems and viral infections, specifically hepatitis B
Xuanmao Jiao, Ph.D. – Associate Professor
William Kinney, PhD  Medicinal chemistry for the discovery of new therapeutics
John Kulp, PhD – Computational Chemistry and Computer Assisted Rational Drug Design, protein modeling
Patrick Lam, Ph.D.  – Medicinal Chemistry; Drug Discovery and development
W. Thomas London, MD – Population Science and HBV Epidemiology
Sung Ryeol Park, PhD  – Medicinal chemistry for the discovery of new therapeutics
Richard Pestell, PhD – Cancer and Regenerative Medicine
Aejaz Sayeed, PhD – Molecular Cell Biology
Ying-Hsiu Su, PhD – Discovery and development of DNA biomarkers of disease; liver and colorectal cancers, DNA sequencing
Matt Todd, PhD – Biochemistry
Roshan Thapa, PhD –  Assistant Professor
Tianlun Zhou, MD, PhD – Translational Medicine and Molecular Virology